The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
The latest biopic on Jyotibai Phule has come at a time when the Department of Taking Offence is super-active. Utkarsh Mishra feels it will be interesting to see if it portrays his attack on Brahminism in the same 'no holds barred' manner-- and, if it does, what reaction it provokes.
The vice-president will be the second Indian to be accorded the honour at the Oxford Centre for Islamic Studies. Nikhil Lakshman reports.
The world is learning about a side effect of the COVID vaccine called Thrombosis with Thrombocytopenia Syndrome, he said.
Dr T V Somanathan is the first finance secretary to be appointed Cabinet secretary since 1985. His appointment at this juncture seems to carry much meaning for the forthcoming trajectory of reforms and restructuring of India's steel frame.
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is unknown, according to court papers being quoted in the UK media.
Delhi faces a severe financial crunch and the deficit is largely due to numerous welfare schemes without adequate revenue flowing in. The success of welfare schemes and electoral promises will need careful financial planning and out of the box thinking to whip up additional revenue, notes Ramesh Menon.
India currently does not have any XBB 1.5 variant-based vaccines available.
rediffGURU Dr Pananjay Tiwari lists the options and cost of pursuing an MBBS education outside of India.
The argument with Nehru happened when Bachchan translated the president's speech in English into Hindi, which in accordance with regular practice was to be delivered by the vice president.
Dr Malhotra, who has demanded a full safety review into the use of AstraZeneca's Covid vaccine, told PTI Covishield "should never have been rolled out in the country in the first place".
India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities.
Dr Samir Shah, who was honoured with a CBE by Queen Elizabeth II in 2019 for services to television and heritage, will replace Richard Sharp, who had been forced to resign after his communication with former prime minister Boris Johnson came under scrutiny.
A number of Indian medical experts on Monday supported calls from an eminent British Indian cardiologist for a full safety review into the use of Oxford/AstraZeneca's Covid-19 vaccine, administered in India as Covishield, over feared serious side effects such as heart attack and stroke.
'For no other leader of India do so many people turn up for an event every year without invitation.'
The Delhi battlefield may not be a cakewalk for the Rhodes Scholar.
Glimpses into the life of Aseefa Bhutto Zardari, who at 31, is Pakistan's youngest first lady.
'It will be interesting to see how Dr Patel handles gadflies with the maturity of egregiously petulant three year olds.' 'That Dr Patel does not, in so far as we can tell, cause society matrons to gush like hormonal teenagers can only be a good thing for him.' 'Look where their febrile imaginations and breathless prose took his predecessor.'
'Having India as a credible deterrent vis-a-vis Chinese ambitions in the Indian Ocean and South Asian region is a desirable short-term outcome.'
Amid concerns over dangerous side-effects of the Oxford's COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said on Saturday.
The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.
Barbie has unveiled their #ThankYouHeroes global doll series featuring frontline workers.
The government on Friday appointed Suman K Bery as the vice chairman of Niti Aayog, following the sudden resignation of Rajiv Kumar.
Sharma was the president of the conference, the first since the Paris Agreement of COP21 that expected parties to make enhanced commitments towards mitigating climate change.
The Drugs Controller General of India will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus.
Economist Abhijit Sen, a former Planning Commission member and one of the country's foremost experts on rural economy, died on Monday night. He was 72.
'A patient visits for any other treatment, but a routine Covid test finds him to be positive.' 'Not only are they, but their whole family is also coming out to be positive.'
The move comes even as India's drug regulator has extended Covishield's shelf life from six to nine months from its manufacturing date.
The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a United Kingdom participant had an adverse reaction to it.
'Assassinating the leaders of an organisation, destroying their homes, buildings and institutions are not 'wiping out' an organisation.' 'Genociding the Lebanese or the Palestinians is something that Israel cannot technically do, let alone morally afford.'
British Indian think tank 1928 Institute organised a special roundtable entitled 'India and the Indo-Pacific' bringing together the High Commissioners of India, Bangladesh, Australia, Canada, Nepal, among others, ahead of the reception in the River Room of the House of Lords on Monday evening.
'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
SII has been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.
The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.
I do think a younger population structure is an advantage against this virus, but there are other important factors such as the capacity of the healthcare system," says Dr Jennifer Dowd, associate professor of demography and population health, University of Oxford.
The Serum Institute of India, Bharat Biotech and Pfizer have applied to the DCGI seeking emergency use authorisation for their COVID-19 vaccine candidates and are awaiting approval.
'If because of El Nino, the monsoon is affected adversely in the current year, naturally it will affect income projections and consequently Budget numbers.'
